Operator of a biopharmaceutical company based in Lausanne, Switzerland. The company specializes in the development of innovative prescription drugs that target unmet medical needs, it also develops drugs for specific indications in the therapeutic areas which include immunology, metabolism, oncology, and infectious diseases, and also offers a wide range of products including Eloxatin for the treatment of colorectal cancer, decapeptide, Telstar, ipamorelin formulations for the treatment of advanced prostate cancer, female infertility, endometriosis, precocious puberty, in-vitro fertilization, uterine fibroids, Mopar, and salvacyl for the treatment of severe sexual deviations.